Clinical Trial Update: A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oral CR845 for pain relief and safety in osteoarthritis of the hip or knee has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip
• Osteoarthritis of the Knee

Drugs mentioned

• CR845 (difelikefalin)

Snippet

Sponsor: Cara Therapeutics, Inc. | Conditions: Osteoarthritis, Hip, Osteoarthritis, Knee | Phase 2 | Status: COMPLETED | Results posted: 2020-10-20